News
Key Takeaways Eli Lilly reported a late-stage study of its oral weight-loss pill met primary and key secondary endpoints.The ...
The once-daily pill also helped 75 per cent of patients who received the highest dose of orforglipron lower their A1C level - ...
Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...
Eli Lilly's experimental GLP-1 pill, orforglipron, showed promising results in a late-stage trial, aiding weight loss by 10.5 ...
The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results